Recent

% | $
Quotes you view appear here for quick access.

Microsoft Corporation Message Board

gadzillionman 121 posts  |  Last Activity: 1 hour 36 minutes ago Member since: Feb 19, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • gadzillionman gadzillionman 1 hour 36 minutes ago Flag

    maybe because your not backing up your PPS estimate with any reasoning ?? Long term bull so hope your right

  • 159 Institutional Holders
    66,014,871 Total Shares Held

    Owner Name

    Date

    Shared Held

    Change (Shares)

    Change (%)

    Value (in 1,000s)

    PAULSON & CO. INC. 09/30/2015 9,000,000 3,218,500 55.67 31,140
    VANGUARD GROUP INC 12/31/2015 6,587,273 116,566 1.80 22,792
    BLACKROCK FUND ADVISORS 12/31/2015 5,310,885 (219,031) (3.96) 18,376
    STATE STREET CORP 09/30/2015 5,105,071 3,337,407 188.80 17,664
    CITADEL ADVISORS LLC 09/30/2015 3,914,655 3,327,408 566.61 13,545
    MILLENNIUM MANAGEMENT LLC 09/30/2015 2,689,859 377,257 16.31 9,307
    BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. 12/31/2015 2,584,484 90,408 3.63 8,942
    ORBIMED ADVISORS LLC 09/30/2015 2,276,648 (844,500) (27.06) 7,877
    INVESCO LTD. 09/30/2015 2,113,843 (328,021) (13.43) 7,314
    FRANKLIN RESOURCES INC 09/30/2015 2,036,467 67,767 3.44 7,046
    JPMORGAN CHASE & CO 09/30/2015 1,155,320 830,625 255.82 3,997

    Sentiment: Buy

  • gadzillionman gadzillionman Feb 10, 2016 2:27 PM Flag

    There is no way they would mention anything about a partnership or buyout, but they do have very capable people in place with vast experience from major pharma co's , but unless I missed it, nothing was mentioned about how to pay for such an expensive launch of Possibly two drugs later this year ? estimated cost of 250-400m. I do hope dilution of shares is NOT on the table !!

  • Hope something they say moves the stock up to where it should be trading at, ? like $7-8 . Long SGYP

    Sentiment: Buy

  • I'm happy to hold my 11,500 shares knowing that I will make some decent profit on a partnership with a larger company or A LOT of profit with a BO ? but 1 of the 2 options will happen late this year. Don't give up longs or listen to any of the mindless postings here & if you are buying or selling stock based on Yahoo posts your as big of idiots as they are & you should probably be out picking up aluminum cans to make extra money instead!!

    Sentiment: Buy

  • Pray for the Fox network to cancel Lucifer before it even airs. And for those people who would make a show celebrating Satan. It is very easy to say “it’s just a television show!” but when it comes to someone’s eternal destiny, it certainly is not. If you are a Christian, reject shows that want to change the image and “brand” of Satan himself while casting God in a negative light. And if you are not a Christian understand that there truly is a battle being waged for your heart, mind and ultimately your soul. Take the time to know God from the Holy Bible, not a TV show or movie – and understand that God does truly love you and wants you to be reconciled to him. And rather than lead you to sin and Hell – He wants to free you from it for eternity.

    Sentiment: Strong Sell

  • Reply to

    Something stinks with synergy

    by aisan0110 Feb 8, 2016 4:05 PM
    gadzillionman gadzillionman Feb 8, 2016 4:23 PM Flag

    The only thing that stinks is you, so hit the shower!! This stock cant go down much farther because too many hedge funds own SGYP & smart investors like myself that understands the fundamentals of the company is holding their shares & only @ a paper loss.

    Sentiment: Strong Buy

  • gadzillionman gadzillionman Feb 7, 2016 2:40 PM Flag

    Because IRWD has had a 5 year head start with Linzess on the market, once the GI doctors start writing prescriptions for Plecanatide sales will increase dramatically, over time sales will outpace IRWD 2to1 . Whoever buys SGYP will have a worldwide sales force in place dedicated to making this happen. Plecanatide is clearly the better drug, its a proven fact & you will hear more about this on the 10th @ the conference in NY!!

  • gadzillionman gadzillionman Feb 7, 2016 1:36 PM Flag

    Many shareholders know that the success of Linzess has already paved the way for Plecanatide, hence the numerous articles on a highly de-risked investment since no patients has had any major issues with taking any indication of Linzess, but the key difference will be that SGYP will be sold to I'm betting Shire so they will certainly reap the rewards with a much better drug & with higher sales!!! while investors will reap the rewards of a BO premium !! Long SGYP

    Sentiment: Buy

  • Reply to

    Conference on wed the 10th outcome for PPS ?

    by gadzillionman Feb 5, 2016 2:57 PM
    gadzillionman gadzillionman Feb 5, 2016 7:21 PM Flag

    Its the stock market that's out of whack !! SGYP is doing everything right , they don't control price of oil, fed rates,inflation, jobs, layoffs,market crashes, HFT, violence in other countries, Politician (H C) with 3 brain cells that tweet about price controls for drugs, a smug scientist on trial for BS, or anything else that would cause negative investor reactions regarding their shares of SGYP. Yeah I pay attention jerkyhawk00.

    Sentiment: Buy

  • Does anyone think the PPS will finally move higher given the fact that the CIC indications probably will turn out better than expected , any peep of a BO would rocket stock to $15, but doubtful anything will be said so maybe we could see $ 5-6 by close of market. Long SGYP

    Sentiment: Buy

  • Reply to

    GUYS, THIS IS GOING TO $4 THEN $45

    by teo_calderon Feb 5, 2016 2:02 PM
    gadzillionman gadzillionman Feb 5, 2016 2:50 PM Flag

    serial killers have all of those attributes lol My prediction is a $30 BO from Shire then I would make $250k in profit so $45 would be ridiculous profit @ $415k After investing in Bio's for 6 years, it would certainly be a Home Run stock for me as well as many other investors !!! Hope your right ? All the best to Longs

    Sentiment: Buy

  • I can see VR being a huge revenue stream because you have these crazy people doing all of these stunts & the normal people would probably pay to see what its like without getting hurt or killed. I can see people with drones shooting footage all over the world & uploading their video for others to watch. Drones will be useful to many ,many people & industries like for security , police , real estate owners & potential buyers, also the media for covering car crashes, or locating lost people & tracking criminals & terrorist . Monetizing all of the data will be key of course but Nick needs to quickly hire some smart visionary people to make GoPro a success instead of buying a yacht & watching lots of crotch. Long GPRO

    Sentiment: Hold

  • Reply to

    new catalyst

    by dizraelian Feb 3, 2016 3:08 PM
    gadzillionman gadzillionman Feb 4, 2016 11:00 AM Flag

    Yes, you are correct Ronsmithsom54, & I'm on your side lol The clinical trials website showed a CIC study that was estimated to be completed in April 2016, now that has changed, so the only indications that are left is the IBS-C3 12wk study due for completion in July 2016 & the last IBS-C3 12wk study to be completed in Aug 2016. I just looked @ website . So things are moving along good, maybe a late summer BO will finally happen ? Long SGYP

    Sentiment: Buy

  • Reply to

    new catalyst

    by dizraelian Feb 3, 2016 3:08 PM
    gadzillionman gadzillionman Feb 3, 2016 4:36 PM Flag

    its now new, but there is another IBS-C P3 that's due in July as well & still waiting on the CIC P3 in April

    Sentiment: Buy

  • gadzillionman by gadzillionman Feb 3, 2016 2:36 PM Flag

    hopefully around $7 or $8 ? Long GPRO

    Sentiment: Hold

  • Reply to

    ORLY buying AAP, already in the works...

    by gadzillionman Jan 29, 2016 12:31 PM
    gadzillionman gadzillionman Feb 1, 2016 3:47 PM Flag

    Money to be made on both sides, but I would lean toward AAP with having the most upside potential with a BO price of $210 & ORLY heading to $300 when not if the deal is announced...

    Sentiment: Strong Buy

  • gadzillionman gadzillionman Feb 1, 2016 2:20 PM Flag

    They are 4 years behind, but they will clearly have the better drugs on the market, so sales of Linzess will decline dramatically !! IRWD will not be bankrupt, but their income will decline starting in 2017.

  • A Shire Buyout Is More Than A Possibility

    In a nutshell, there are 4 reasons why Shire would be interested in acquiring Synergy.
    •Plecanatide is a complementary asset to Shire's growing portfolio of digestive disorder products.
    •Shire's reputation for pricey specialty therapeutics with extensive market exclusivity would put plecanatide in the hands of high prescribing gastroenterologists right off.
    •Shire's product revenues, which were flat this past quarter due only to the erosion of Intuniv revenue from generic competition, would receive a big boost.
    •And Shire would place a promising late-stage compound into its already long list of pipeline candidates - dolcanatide (formerly SP-333) which could command a huge stake of the Opioid Induced Constipation market valued at $2B annually by AstraZeneca (NYSE:AZN)

    Any company willing to buy Synergy Pharmaceuticals will need to have a worldwide sales force already in place and a commercial portfolio that lends itself to easily distributing plecanatide.

    Sentiment: Buy

  • Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change. This key amino acid substitution provides improved stability and an 8-fold higher binding constant to the GC-C receptor. Taken as a tablet once-a-day, plecanatide, like uroguanylin, operates in a pH-dependent manner, exerting its activity primarily in the upper GI tract to facilitate fluid movement required for regular bowel function. GADZ is long SGYP

    Sentiment: Buy

MSFT
50.50+0.81(+1.63%)Feb 12 4:00 PMEST